These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary. Pietersz GA, Cunningham Z, McKenzie IF. Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():43-9. PubMed ID: 3372005 [Abstract] [Full Text] [Related]
11. Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates. Smyth MJ, Foster HM, Andrew SM, Teh JG, Krauer K, McKenzie IF, Pietersz GA. Immunol Cell Biol; 1993 Jun 01; 71 ( Pt 3)():167-79. PubMed ID: 8349300 [Abstract] [Full Text] [Related]
12. Synthesis of site-specific methotrexate-IgG conjugates. Comparison of stability and antitumor activity with active-ester-based conjugates. Kralovec J, Singh M, Mammen M, Blair AH, Ghose T. Cancer Immunol Immunother; 1989 Jun 01; 29(4):293-302. PubMed ID: 2787696 [Abstract] [Full Text] [Related]
13. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity. Pietersz GA, Kanellos J, McKenzie IF. Cancer Res; 1988 Aug 15; 48(16):4469-76. PubMed ID: 3260814 [Abstract] [Full Text] [Related]
14. Increased antitumor effect of immunoconjugates and tumor necrosis factor in vivo. Smyth MJ, Pietersz GA, McKenzie IF. Cancer Res; 1988 Jul 01; 48(13):3607-12. PubMed ID: 3259905 [Abstract] [Full Text] [Related]
15. Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs. Rowland AJ, McKenzie IF, Pietersz GA. J Drug Target; 1994 Jul 01; 2(2):113-21. PubMed ID: 8069589 [Abstract] [Full Text] [Related]
16. Effect of tumor necrosis factor on the antitumor efficacy and toxicity of aminopterin-monoclonal antibody conjugates: parameters for optimization of therapy. Russell SM, Krauer KG, McKenzie IF, Pietersz GA. Cancer Res; 1990 Sep 15; 50(18):6028-33. PubMed ID: 2393867 [Abstract] [Full Text] [Related]
17. A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate. Pimm MV, Robins RA, Embleton MJ, Jacobs E, Markham AJ, Charleston A, Baldwin RW. Br J Cancer; 1990 Apr 15; 61(4):508-13. PubMed ID: 2331436 [Abstract] [Full Text] [Related]
18. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates. Endo N, Takeda Y, Umemoto N, Kishida K, Watanabe K, Saito M, Kato Y, Hara T. Cancer Res; 1988 Jun 15; 48(12):3330-5. PubMed ID: 3259466 [Abstract] [Full Text] [Related]
19. Preparation and characterization of methotrexate-immunoglobulin conjugates. Ghosh MK, Kildsig DO, Mitra AK. Drug Des Deliv; 1989 Jan 15; 4(1):13-25. PubMed ID: 2789065 [Abstract] [Full Text] [Related]
20. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells. Shen WC, Ballou B, Ryser HJ, Hakala TR. Cancer Res; 1986 Aug 15; 46(8):3912-6. PubMed ID: 2873883 [Abstract] [Full Text] [Related] Page: [Next] [New Search]